To our knowledge, the only relevant study by Vessby et al. [9] analyzed nine PSC-IBD patients and seven UC patients in clinical and histologic remission, and seven healthy controls, identifying AGPAT1 protein as a potential PSC-IBD marker. This evidence concerns the gene AGPAT1 and inflammatory bowel disease.